{"id":12252,"date":"2015-03-04T17:09:56","date_gmt":"2015-03-04T16:09:56","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=12252"},"modified":"2015-03-04T17:09:56","modified_gmt":"2015-03-04T16:09:56","slug":"tractament-del-vih-quina-es-la-situacio-de-la-vacuna","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/","title":{"rendered":"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna?"},"content":{"rendered":"
\"Human_Immunodeficency_Virus_-_stylized_rendering\"<\/a>
Diagrama d’una secci\u00f3 del virus de la immunodefici\u00e8ncia humana (simulaci\u00f3 gr\u00e0fica). Font: Los Alamos National Laboratory – Wikimedia Commons<\/figcaption><\/figure>\n

La infecci\u00f3 del Virus de la immunodefici\u00e8ncia humana (VIH)<\/strong> i la gran incid\u00e8ncia que ha tingut en la poblaci\u00f3 mundial han propiciat un canvi quantitatiu i qualitatiu en la investigaci\u00f3. Els aven\u00e7os dels \u00faltims anys han perm\u00e8s ampliar el coneixement sobre el virus, definir les pautes de tractament antiretroviral, fixar les bases per al desenvolupament de vacunes, incorporar noves estrat\u00e8gies d\u2019eradicaci\u00f3 i fer de la retrovirologia humana una de les \u00e0rees m\u00e9s din\u00e0miques de la biomedicina. La recerca biom\u00e8dica de medicaments incorpora f\u00e0rmacs nous als sistemes sanitaris i, a\u00a0vegades, quan aquests f\u00e0rmacs es comencen a comercialitzar, l\u2019evid\u00e8ncia de l\u2019efectivitat i la seguretat encara \u00e9s parcial o insuficient, especialment pel que fa a dades comparatives amb altres alternatives terap\u00e8utiques.<\/p>\n

Per tal d’aprofundir en el coneixement de les noves estrat\u00e8gies en el tractament antiretroviral (TAR), evidenciar el cost-efic\u00e0cia del TAR i exposar la situaci\u00f3 actual de la vacuna pel VIH, el Col\u00b7legi va organitzar el 5 de febrer, conjuntament amb la\u00a0Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/a><\/span>\u00a0(SCFC), la confer\u00e8ncia \u201cActualitzaci\u00f3 en el tractament del VIH. Situaci\u00f3 de la vacuna\u201d a la que van assistir\u00a0farmac\u00e8utics d\u2019hospitals, de centres d\u2019atenci\u00f3 prim\u00e0ria i de l\u2019administraci\u00f3 sanit\u00e0ria.<\/p>\n

Tom\u00e0s Casas\u00edn<\/b> (vocal d\u2019Hospitals del COFB) coordinador de l\u2019acte -juntament amb Julio Mart\u00ednez d\u2019SCFC- destaca alguns dels punts m\u00e9s interessants tractats a la confer\u00e8ncia:<\/p>\n

En la primera pon\u00e8ncia, Actualitzaci\u00f3 en el tractament del VIH. Noves estrat\u00e8gies de tractament,<\/b><\/em> Esteve Ribera<\/strong>, cap cl\u00ednic de la Unitat VIH, Hospital Universitari Vall d\u2019Hebron de Barcelona, va parlar de les ter\u00e0pies lliures d\u2019an\u00e0legs recollides a les guies de tractament antiretroviral internacionals i es va realitzar una revisi\u00f3 de l\u2019evid\u00e8ncia cient\u00edfica, novetats publicades de les ter\u00e0pies lliures d\u2019an\u00e0legs comparades amb les ter\u00e0pies triples i monoter\u00e0pia, aprofundint en quins factors del pacient cal tenir en compte a l\u2019hora d\u2019iniciar el tractament i quins s\u00f3n candidats a les diferents opcions terap\u00e8utiques, tenint en compte la pr\u00f2pia experi\u00e8ncia cl\u00ednica com a factor que pot predisposar.<\/p>\n

\"actualitzacioVIH<\/p>\n

Del tractament amb nous inhibidors de la integrasa, tant en pacient na\u00eff com en pacient no na\u00eff, Ribera va destacar la seva efic\u00e0cia, major pot\u00e8ncia, millor perfil de seguretat i baix grau d\u2019interaccions. Tamb\u00e9 es va fer una reflexi\u00f3 sobre la falta de estudis i experi\u00e8ncia cl\u00ednica a m\u00e9s llarg termini.<\/strong><\/span><\/p>\n

La segona pon\u00e8ncia,\u00a0El punt de vista del farmac\u00e8utic. Cost-efic\u00e0cia<\/em>, va anar a c\u00e0rrec de Joaqu\u00edn Mach\u00ed<\/strong>, farmac\u00e8utic \"actualitzacioVIH<\/a>especialista del Servei de Farm\u00e0cia de l\u2019Hospital de Viladecans, i va posar en evid\u00e8ncia que la utilitzaci\u00f3 de les diferents estrat\u00e8gies terap\u00e8utiques tenen una repercussi\u00f3 econ\u00f2mica molt important en un entorn de recursos limitats com \u00e9s el sanitari. Es va destacar la falta de coher\u00e8ncia entre les noves guies publicades pel grup d\u2019estudi de la SEIMC (Societat Espanyola de Malalties Infeccioses i Microbiologia Cl\u00ednica) GeSIDA<\/a> i la tarifa plana que ha instaurat CatSalut com a sistema de pagament pels tractaments antiretrovirals, deixant entreveure que aquest sistema de control de la despesa pot ser inviable o molt dif\u00edcil de complir. Es\u00a0 va analitzar el cost-efic\u00e0cia dels tractaments existents a les guies GeSIDA 2015 i de les ter\u00e0pies lliures d\u2019an\u00e0legs existents, aix\u00ed com de les biter\u00e0pies i monoter\u00e0pies.<\/p>\n

Import\u00e0ncia d\u2019incorporar elements de variables cost-efic\u00e0cia o cost-efectivitat a l\u2019hora de decidir entre diferents estrat\u00e8gies terap\u00e8utiques en el tractament antiretroviral.<\/strong><\/span><\/p>\n

En la tercera pon\u00e8ncia, Experi\u00e8ncia en simplificaci\u00f3 del tractament antiretroviral<\/em>, Joaqu\u00edn Serrano<\/strong>, farmac\u00e8utic del Servei de Farm\u00e0cia de l’Hospital Son Ll\u00e0tzer de Palma de Mallorca, va fer una descripci\u00f3 detallada de l\u2019experi\u00e8ncia en simplificaci\u00f3 a aquest hospital.<\/p>\n

Bons resultats amb biter\u00e0pies i sobretot en monoter\u00e0pies tot i la desconfian\u00e7a, que va en augment, a l\u2019hora d’utilitzar aquestes estrat\u00e8gies.<\/strong><\/span><\/p>\n

Per a concloure l\u2019acte, Beatriz Mothe<\/strong>, de la Fundaci\u00f3 Irsicaixa de l\u2019Hospital Germans Trias i Pujol de Badalona, va parlar de la Situaci\u00f3 de la vacuna contra el VIH<\/em>.<\/em> <\/b>Va exposar amb molt detall la situaci\u00f3 actual de la vacuna per al VIH i les bases per al desenvolupament de noves vacunes, destacant la dificultat de sintetitzar una vacuna que resulti efica\u00e7.<\/p>\n

Import\u00e0ncia de la recerca biom\u00e8dica en el camp dels diferents tipus de vacunes preventives o terap\u00e8utiques, i dificultat per trobar un indicador adequat per monitoritzar la seva efic\u00e0cia, deixant ben clar que encara queda molt cam\u00ed a rec\u00f3rrer en la troballa d\u2019una vacuna adequada.<\/strong><\/span><\/p>\n

<\/a>VIH: Programa de detecci\u00f3 mitjan\u00e7ant test r\u00e0pid<\/b><\/p>\n

Con\u00e8ixer aviat la possibilitat d’estar infectat pel virus de la sida, permet un diagn\u00f2stic preco\u00e7, i establir un tractament el m\u00e9s aviat possible millora extraordin\u00e0riament el pron\u00f2stic. La determinaci\u00f3 de la infecci\u00f3 per VIH mitjan\u00e7ant un test r\u00e0pid a les oficines de farm\u00e0cia pret\u00e9n afavorir l’accessibilitat al diagn\u00f2stic a totes aquelles persones que presentin conductes de risc per a la infecci\u00f3. La prova, que dura uns 20 minuts, \u00e9s totalment an\u00f2nima.<\/p>\n

Consulta el llistat de farm\u00e0cies que participa<\/a><\/span>.<\/div><\/p>\n

Amb el patrocini de:<\/b><\/p>\n

\u00a0\"janssen_logo\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

La infecci\u00f3 del Virus de la immunodefici\u00e8ncia humana (VIH) i la gran incid\u00e8ncia que ha tingut en la poblaci\u00f3 mundial han propiciat un canvi quantitatiu i qualitatiu en la investigaci\u00f3. Els aven\u00e7os dels \u00faltims anys han perm\u00e8s ampliar el coneixement sobre el virus, definir les pautes de tractament antiretroviral, fixar […]<\/p>\n","protected":false},"author":1,"featured_media":12258,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[480,70,232],"class_list":["post-12252","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-farmacia-hospitalaria","tag-formacio","tag-vih"],"yoast_head":"\nTractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna? - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La infecci\u00f3 del Virus de la immunodefici\u00e8ncia humana (VIH) i la gran incid\u00e8ncia que ha tingut en la poblaci\u00f3 mundial han propiciat un canvi quantitatiu i qualitatiu en la investigaci\u00f3. Els aven\u00e7os dels \u00faltims anys han perm\u00e8s ampliar el coneixement sobre el virus, definir les pautes de tractament antiretroviral, fixar […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-04T16:09:56+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna?\",\"datePublished\":\"2015-03-04T16:09:56+00:00\",\"dateModified\":\"2015-03-04T16:09:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/\"},\"wordCount\":961,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"farm\u00e0cia hospital\u00e0ria\",\"Formaci\u00f3\",\"VIH\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/\",\"name\":\"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-03-04T16:09:56+00:00\",\"dateModified\":\"2015-03-04T16:09:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/","og_locale":"ca_ES","og_type":"article","og_title":"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"La infecci\u00f3 del Virus de la immunodefici\u00e8ncia humana (VIH) i la gran incid\u00e8ncia que ha tingut en la poblaci\u00f3 mundial han propiciat un canvi quantitatiu i qualitatiu en la investigaci\u00f3. Els aven\u00e7os dels \u00faltims anys han perm\u00e8s ampliar el coneixement sobre el virus, definir les pautes de tractament antiretroviral, fixar […]","og_url":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-03-04T16:09:56+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna?","datePublished":"2015-03-04T16:09:56+00:00","dateModified":"2015-03-04T16:09:56+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/"},"wordCount":961,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage"},"thumbnailUrl":"","keywords":["farm\u00e0cia hospital\u00e0ria","Formaci\u00f3","VIH"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/","url":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/","name":"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-03-04T16:09:56+00:00","dateModified":"2015-03-04T16:09:56+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/04\/tractament-del-vih-quina-es-la-situacio-de-la-vacuna\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Tractament del VIH: quina \u00e9s la situaci\u00f3 de la vacuna?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":1,"uagb_excerpt":"La infecci\u00f3 del Virus de la immunodefici\u00e8ncia humana (VIH) i la gran incid\u00e8ncia que ha tingut en la poblaci\u00f3 mundial han propiciat un canvi quantitatiu i qualitatiu en la investigaci\u00f3. Els aven\u00e7os dels \u00faltims anys han perm\u00e8s ampliar el coneixement sobre el virus, definir les pautes de tractament antiretroviral, fixar […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/12252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=12252"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/12252\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=12252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=12252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=12252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}